Mork Capital Management’s GSK GSK Stock Holding History

Mork Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,504	Closed	-$545K	–	128
2022 Q3	$545K	Hold	18,504	–	–	0.54%	95
2022 Q2	$1.01M	Hold	18,504	–	–	0.92%	45
2022 Q1	$1.01M	Sell	18,504 -2,696	-13%	-$146K	0.91%	57
2021 Q4	$1.17M	Hold	21,200	–	–	0.79%	53
2021 Q3	$1.01M	Hold	21,200	–	–	0.86%	65
2021 Q2	$1.05M	Hold	21,200	–	–	0.76%	75
2021 Q1	$946K	Buy	+21,200	New	+$962K	0.72%	83
2017 Q4	–	Sell	-17,760	Closed	-$901K	–	127
2017 Q3	$901K	Hold	17,760	–	–	0.73%	68
2017 Q2	$957K	Hold	17,760	–	–	0.82%	55
2017 Q1	$936K	Hold	17,760	–	–	0.83%	51
2016 Q4	$855K	Buy	+17,760	New	+$877K	0.6%	79

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mork Capital Management's GSK Position: Q4 2022 in Review

Mork Capital Management sold out of GSK (GSK) in Q4 2022, closing a stake of 18,504 shares — an estimated $545K sold.

Mork Capital Management first reported a position in GSK in Q4 2016 and held it in 11 quarters. The position peaked at $1.17M in Q4 2021. 814 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

Mork Capital Management reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
Mork Capital Management sold 18,504 GSK shares in Q4 2022, an estimated $545K.
Mork Capital Management first reported a position in GSK in Q4 2016 and held it in 11 quarters.
Mork Capital Management's GSK position peaked at $1.17M in Q4 2021.
814 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Mork Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.